Q1 earnings: Aurobindo Pharma net loss seen at Rs 65 cr

NEW DELHI: Aurobindo Pharma Ltd will announce its quarterly results today. The company is expected to post a net loss of Rs 65 crore for the quarter ended June 2012, against a net loss of Rs 123 crore YoY, according to ET Now estimates.

A forex loss of Rs 150-180 crore is likely in the same quarter.

Net sales are expected to have grown to Rs 1,248 crore, up 16 per cent YoY from Rs 1,077 crore.

Earnings before interest, taxes, depreciation and amortization or (EBITDA) are seen inching up by 10 per cent to Rs 180 crore against Rs 164 crore in the year-ago-period.

Margins for the pharmaceutical major are seen at 14.4 per cent compared to 15.2 per cent in the year-ago period.

Things to watch out for:

Forex loss of Rs 150 cr-180 cr is expected in Q1

Formulations business to lead growth for the company

US FDA ban will impact profits of the company in this quarter

Company had an exceptional loss of Rs 320 cr last yr due to FCCB repayment